Genworth Financial Earnings Call Transcripts
Fiscal Year 2026
-
The meeting highlighted strong 2025 financial results, robust share repurchases, and strategic progress in CareScout and technology initiatives. All board proposals passed with strong support, while regulatory and business hurdles were discussed regarding a potential Enact spin-off.
-
Q1 2026 saw strong Enact performance, $109M adjusted operating income (ex-Closed Block), and $66M in share repurchases. CareScout expanded its network and targets $25M in 2026 revenue, while the Closed Block remains self-sustaining with no capital contributions planned.
Fiscal Year 2025
-
Q4 2025 saw strong Enact performance offset by LTC losses, with net income of $2 million and $8 million Adjusted Operating Income. Strategic priorities advanced, including CareScout’s expansion and new product launch, while capital returns and investments remained robust.
-
Q3 2025 saw $116M net income and $17M adjusted operating income, led by Enact's strong results and capital returns. CareScout expanded its network, completed the Seniorly acquisition, and launched a new LTC insurance product, while LTC legacy business remains in long-term run-off.
-
Q2 2025 saw $51M net income and $68M adjusted operating income, with Enact driving results and expected to return $400M to shareholders this year. CareScout expanded its offerings and network, while a favorable AXA litigation outcome could yield $750M, pending appeals.
-
Q1 2025 saw $54M net income and $51M adjusted operating income, led by Enact's strong results and capital returns. CareScout expanded rapidly, and the company maintained robust liquidity and capital allocation, while preparing for new product launches and navigating macroeconomic and legal uncertainties.
Fiscal Year 2024
-
Q4 saw a net loss of $1M but strong full-year results, with $299M net income and $273M adjusted operating income, led by Enact's record performance. CareScout expanded rapidly, and significant progress was made on debt reduction, share repurchases, and LTC risk mitigation.
-
Q3 2024 saw strong Enact performance, robust capital returns, and continued progress on LTC rate actions and CareScout expansion. Net income was $85M, with $148M in adjusted operating income from Enact and $369M in liquidity. Share repurchases and debt reduction remain key priorities.
-
Q2 2024 saw strong earnings led by Enact, with $125M adjusted operating income and robust capital returns. LTC statutory results benefited from rate actions, while CareScout expanded its network to 70% coverage of the age 65+ population, targeting 85% by year-end.